Petlife Pharmaceuticals (PTLF) Income Statement

1 Followers

Petlife Pharmaceuticals Income Statement

Last quarter (Q2 2018), Petlife Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Petlife Pharmaceuticals's net income was $-427.06K. See Petlife Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Aug 17
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 22.66M
Depreciation and Amortization	$ 0.00
EBITDA	$ -22.87M
Operating Income	$ -22.66M
Other Income/Expenses	$ -601.47K
Pretax Income	$ -23.26M
Net Income	$ -23.26M
Per Share Metrics
Basic EPS	$ -0.33
Diluted EPS	$ -0.33
Weighted Average Shares Outstanding	68.81M
Weighted Average Shares Outstanding (Diluted)	68.81M

Currency in USD

Petlife Pharmaceuticals (PTLF) Income Statement

Petlife Pharmaceuticals Income Statement

Petlife Pharmaceuticals Earnings and Revenue History